Rohto Pharmaceutical and Oishii Plus have signed a capital and business alliance agreement.

management

Products/Business

Alliance

Rohto Pharmaceutical and Oishii Plus have signed a capital and business alliance agreement to combine "deliciousness" and "health" and collaborate towards realizing a sustainable healthy society.

May 18, 2023

ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture; President and Representative Director: Masafumi Sugimoto) has entered into a capital and business alliance agreement with Oishii Plus Co., Ltd. (Headquarters: Shibuya Ward, Tokyo; President and Representative Director: Osamu Ito; hereinafter referred to as "Oishii Plus") with the aim of collaborating to promote the realization of a sustainable healthy society by combining "deliciousness" and "health" in the food business.

Background and Objectives of the Initiative

Our company aims to be a "pharmaceutical company that doesn't rely too heavily on medicine" in the food business, and we have challenged ourselves to develop various functional foods and food products through evidence-based manufacturing that we have cultivated over the years. In a changing society, we strive to promote well-being in the most optimal way for each individual, by utilizing cutting-edge technology while staying close to our customers' lifestyles and eating habits.
Oishii Plus aims to provide customers with an unforgettable experience by thoroughly balancing "deliciousness" and "health," and to create a sustainable approach to food. While setting standards such as low sugar and low salt content in product development, we strive to create products that are as delicious as, or even better than, everyday meals. As the importance of "food" in supporting daily health continues to grow, we aim to develop food products based on evidence and trust.
We have entered into a capital and business alliance with Oishii Plus, believing that this partnership will enable us to provide next-generation food products that prioritize deliciousness. Through this collaboration, we expect to see not only strengthened marketing and expanded sales networks, but also the creation of new food tech products.

Details of the partnership

Our company and Oishii Plus aim to achieve both "deliciousness" and "health" by collaborating on various initiatives, including the application of functional food ingredients, joint research and development of health foods and functional foods utilizing food technology, and cooperation in marketing strategies and planning and sales that leverage each other's sales networks.
This capital and business alliance will involve a third-party allocation of shares, in which Rohto Pharmaceutical will acquire newly issued shares from Oishii Plus.

Oishii Plus Co., Ltd. Overview

Founded in 2014 by Chef Shintaro Ezaki (current Chairman of the Board), who earned three Michelin stars in the "Michelin Guide Tokyo" for seven consecutive years, the company aims to "reduce obesity and disease in Chairman and Representative Director" by combining "deliciousness" and "health."
While being "low in carbohydrates," "low in salt," and "naturally derived," we strive to achieve a "deliciousness" that is equal to or even greater than the "deliciousness" of the unrestricted meals that many people eat every day, thereby contributing to the creation of a sustainable and healthy society. In addition to in-store sales at Isetan Shinjuku and Ecute Tokyo Station, we are building a system that allows people to purchase next-generation foods on a daily basis by selling frozen bento boxes and sweets on our e-commerce site using a subscription model.

https://www.oishiiplus.com/

Future outlook

The impact of this matter on our consolidated financial results for the fiscal year ending March 2024 is expected to be minor, and we will promptly inform you of any further matters that need to be disclosed.

​